Sort
48,018 grants matching “immunotherapy”
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$2,125,238Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Role of microbiome in cancer and inflammation
$2,124,656Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
CLINICAL EVALUATION OF COMBINATION IMMUNOTHERAPY FOR RENAL CELL CARCINOMA (RCC)
$2,124,536Mayo Clinic · · FY2025 · Defense Health Agency
Mechanisms of peripheral induction of T-cell tolerance
$2,123,951Kristin A. Hogquist · University Of Minnesota · P01 · FY2022 · AI
SAN DIEGO AIDS CLINICAL TRIAL UNIT
$2,123,616University Of California San Diego · U01 · FY2004 · AI
Melanoma and Skin Cancer Program SPORE
$2,121,665Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2024 · CA
Center for Applied Immunology and Pathological Processes
$2,121,498Andrew D Yurochko · Louisiana State Univ Hsc Shreveport · P20 · FY2023 · GM
Mayo Clinic Multiple Myeloma SPORE
$2,120,249Peter Leif Bergsagel · Mayo Clinic Arizona · P50 · FY2019 · CA
Targeting Lung Cancer Vulnerabilities
$2,120,114John D Minna · Ut Southwestern Medical Center · P50 · FY2022 · CA
Surgery Branch Cell Prep Core
$2,119,096Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Cell Production Core Facility
$2,119,096Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
The CSBC Research Center for Cancer Systems Immunology at MSKCC
$2,119,051Christina S Leslie · Sloan-Kettering Inst Can Research · U54 · FY2016 · CA
Specialized Program Of Research Excellence (SPORE) in Leukemia.
$2,117,606Daniel C Link · Washington University · P50 · FY2019 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,117,028Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Preclinical drug development in pancreatic cancer
$2,113,368Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Head and Neck Cancer SPORE
$2,112,973Robert L Ferris · University Of Pittsburgh At Pittsburgh · P50 · FY2023 · CA
UCLA SPORE in Brain Cancer
$2,112,473Linda M Liau · University Of California Los Angeles · P50 · FY2024 · CA
Radiation-induced molecular targets
$2,111,063Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Targeting Lung Cancer Vulnerabilities
$2,110,656John D Minna · Ut Southwestern Medical Center · P50 · FY2023 · CA
Surgery Branch Cell Prep Core
$2,110,232Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Cell Production Core Facility
$2,110,232Hyunmi Halas · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Specialized Program of Research Excellence (SPORE) in Leukemia
$2,109,864Daniel C Link · Washington University · P50 · FY2024 · CA
Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases
$2,109,490Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
NYU Melanoma SPORE
$2,109,068Iman Osman · New York University School Of Medicine · P50 · FY2020 · CA
Detection, prevention and treatment of acute myeloid leukemia (AML) relapse.
$2,106,043Christopher Hourigan · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL